Hip Activation and FSDT

Does a Hip Muscle Activation Home Exercise Program Change Patient Performance on the Forward Step-Down Test? A Single-Arm Clinical Trail

The purpose of this study is to determine if activation training of the hip musculature affects muscle activation and frontal plane mechanics in healthy individuals.

Specific Aim 1: Determine whether performance on the forward step-down test (FSDT) changes after an eight-week home exercise program (HEP) focused on hip musculature activation in healthy individuals.

Specific Aim 2: Determine whether surface electromyography (sEMG) hip musculature changes following an eight-week HEP focused on hip musculature activation in healthy individuals.

Specific Aim 3: Determine whether a dose-response relationship exists between compliance on the HEP and changes in FSDT scores in healthy individuals.

Specific Aim 4: Determine whether a dose-response relationship exists between compliance on the HEP and sEMG changes in hip musculature activation in healthy individuals.

Study Overview

• Status: Completed
• Conditions: Lower Extremity Problem; Movement, Abnormal
• Intervention / Treatment: Other: Hip muscle activation home exercise program

• Study Type: Interventional
• Enrollment (Actual): 35
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Louisiana
    • Shreveport, Louisiana, United States, 71130
      • Louisiana State University Health Sciences Center - Shreveport

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Participants must be current first or second year Doctor of Physical Therapy students in the School of Allied Health Professions at LSU Health Shreveport.

Exclusion Criteria:

• Current knee pain or pathology in the dominant leg, and women with known pregnancy.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Arm 1; Participants will undergo lower extremity movement assessment on the Forward Step Down Test before and after a home exercise program (HEP) consisting of five hip activation exercises. These exercises will be performed 2x/week for 8 weeks. Surface EMG of the gluteus maximus and medius, in addition to tracking of participant compliance on the HEP program will also be assessed pre- and post-intervention.

Other: Hip muscle activation home exercise program; Participants will perform a home exercise program consisting of five hip muscle activation exercises with the use of a resistance band. The program will be eight weeks in duration, and participants will perform the exercises twice weekly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Scores on the Forward Step Down Test	Participants will perform the Forward Step Down Test pre- and post-intervention, while being score by two investigators simultaneously.	Pre- and Post- Intervention Program (8 weeks)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Surface electromyography (sEMG) - Gluteus Maximus	sEMG data for the gluteus maximus, including both mean EMG activation and peak EMG activation will be recorded during performance of the Forward Step Down Test.	Pre- and Post- Intervention Program (8 weeks)
Surface electromyography (sEMG) - Gluteus Medius	sEMG data for the gluteus medius, including both mean EMG activation and peak EMG activation will be recorded during performance of the Forward Step Down Test.	Pre- and Post- Intervention Program (8 weeks)
Home Exercise Program (HEP) Compliance	Participants will complete a log of the number of HEP sessions they complete during the 8-week intervention program. The sum of sessions completed will be used as a measure of compliance.	Pre- and Post- Intervention Program (8 weeks)

Collaborators and Investigators

• Sponsor: Louisiana State University Health Sciences Center Shreveport
• Investigators: Principal Investigator: Daniel W. Flowers, DPT, PhD, Louisiana State University Health Sciences Center Shreveport

Study record dates

Study Major Dates

• Study Start (Actual): January 26, 2023
• Primary Completion (Actual): April 28, 2023
• Study Completion (Actual): April 28, 2023

Study Registration Dates

• First Submitted: November 28, 2022
• First Submitted That Met QC Criteria: December 6, 2022
• First Posted (Actual): December 8, 2022

Study Record Updates

• Last Update Posted (Actual): May 1, 2023
• Last Update Submitted That Met QC Criteria: April 28, 2023
• Last Verified: April 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Movement Disorders; Dyskinesias
• Other Study ID Numbers: STUDY00002264

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No